Your browser doesn't support javascript.
loading
Cancer origin tracing and timing in two high-risk prostate cancers using multisample whole genome analysis: prospects for personalized medicine.
Nurminen, Anssi; Jaatinen, Serafiina; Taavitsainen, Sinja; Högnäs, Gunilla; Lesluyes, Tom; Ansari-Pour, Naser; Tolonen, Teemu; Haase, Kerstin; Koskenalho, Antti; Kankainen, Matti; Jasu, Juho; Rauhala, Hanna; Kesäniemi, Jenni; Nikupaavola, Tiia; Kujala, Paula; Rinta-Kiikka, Irina; Riikonen, Jarno; Kaipia, Antti; Murtola, Teemu; Tammela, Teuvo L; Visakorpi, Tapio; Nykter, Matti; Wedge, David C; Van Loo, Peter; Bova, G Steven.
Afiliação
  • Nurminen A; Faculty of Medicine and Health Technology, Prostate Cancer Research Center, Tampere University and Tays Cancer Center, PO Box 100, 33014, Tampere, Finland.
  • Jaatinen S; Faculty of Medicine and Health Technology, Prostate Cancer Research Center, Tampere University and Tays Cancer Center, PO Box 100, 33014, Tampere, Finland.
  • Taavitsainen S; Faculty of Medicine and Health Technology, Prostate Cancer Research Center, Tampere University and Tays Cancer Center, PO Box 100, 33014, Tampere, Finland.
  • Högnäs G; Faculty of Medicine and Health Technology, Prostate Cancer Research Center, Tampere University and Tays Cancer Center, PO Box 100, 33014, Tampere, Finland.
  • Lesluyes T; The Francis Crick Institute, London, NW1 1AT, UK.
  • Ansari-Pour N; MRC Molecular Haematology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
  • Tolonen T; Fimlab Laboratories, Department of Pathology, Tampere University Hospital, Tampere, Finland.
  • Haase K; The Francis Crick Institute, London, NW1 1AT, UK.
  • Koskenalho A; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität Zu Berlin, ECRC Experimental and Clinical Research Center, Berlin, Germany.
  • Kankainen M; Faculty of Medicine and Health Technology, Prostate Cancer Research Center, Tampere University and Tays Cancer Center, PO Box 100, 33014, Tampere, Finland.
  • Jasu J; Institute for Molecular Medicine Finland, University of Helsinki, Tukholmankatu 8, Helsinki, 00290, Finland.
  • Rauhala H; Faculty of Medicine and Health Technology, Prostate Cancer Research Center, Tampere University and Tays Cancer Center, PO Box 100, 33014, Tampere, Finland.
  • Kesäniemi J; Faculty of Medicine and Health Technology, Prostate Cancer Research Center, Tampere University and Tays Cancer Center, PO Box 100, 33014, Tampere, Finland.
  • Nikupaavola T; Faculty of Medicine and Health Technology, Prostate Cancer Research Center, Tampere University and Tays Cancer Center, PO Box 100, 33014, Tampere, Finland.
  • Kujala P; Faculty of Medicine and Health Technology, Prostate Cancer Research Center, Tampere University and Tays Cancer Center, PO Box 100, 33014, Tampere, Finland.
  • Rinta-Kiikka I; Fimlab Laboratories, Department of Pathology, Tampere University Hospital, Tampere, Finland.
  • Riikonen J; Imaging Centre, Department of Radiology, Tampere University Hospital, Tampere, Finland.
  • Kaipia A; Department of Urology, TAYS Cancer Center, Tampere University Hospital, Tampere, Finland.
  • Murtola T; Department of Urology, TAYS Cancer Center, Tampere University Hospital, Tampere, Finland.
  • Tammela TL; Faculty of Medicine and Health Technology, Prostate Cancer Research Center, Tampere University and Tays Cancer Center, PO Box 100, 33014, Tampere, Finland.
  • Visakorpi T; Department of Urology, TAYS Cancer Center, Tampere University Hospital, Tampere, Finland.
  • Nykter M; Faculty of Medicine and Health Technology, Prostate Cancer Research Center, Tampere University and Tays Cancer Center, PO Box 100, 33014, Tampere, Finland.
  • Wedge DC; Department of Urology, TAYS Cancer Center, Tampere University Hospital, Tampere, Finland.
  • Van Loo P; Faculty of Medicine and Health Technology, Prostate Cancer Research Center, Tampere University and Tays Cancer Center, PO Box 100, 33014, Tampere, Finland.
  • Bova GS; Fimlab Laboratories, Department of Pathology, Tampere University Hospital, Tampere, Finland.
Genome Med ; 15(1): 82, 2023 10 12.
Article em En | MEDLINE | ID: mdl-37828555
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata Limite: Humans / Male / Middle aged Idioma: En Revista: Genome Med Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Finlândia País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata Limite: Humans / Male / Middle aged Idioma: En Revista: Genome Med Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Finlândia País de publicação: Reino Unido